Clinical trial
An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
NCT05209906 is registered in ClinicalTrials.gov with Mackay Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
- Lead sponsor
- Mackay Memorial Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 6, 2019
- Completion date
- August 15, 2022
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.